(Q37953791)

25 August 2017

The worldwide epidemiology of type 2 diabetes mellitus--present and future perspectives (English)

1 reference

25 August 2017

0 references

Lei Chen

1

0 references

Paul Zimmet

object named as

Paul Z Zimmet

series ordinal

3

0 references

author name string

Dianna J Magliano

series ordinal

2

1 reference

25 August 2017

8 November 2011

1 reference

Nature Reviews Endocrinology

25 August 2017

1 reference

25 August 2017

8

1 reference

25 August 2017

228-236

1 reference

25 August 2017

4

1 reference

https://scigraph.springernature.com/pub.10.1038/nrendo.2011.183

25 August 2017

0 references

cites work

Global and societal implications of the diabetes epidemic

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.183

National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.183

Global estimates of the prevalence of diabetes for 2010 and 2030

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.183

Diabetes in Asia: epidemiology, risk factors, and pathophysiology

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.183

High prevalence of NIDDM and impaired glucose tolerance in Indian, Creole, and Chinese Mauritians. Mauritius Noncommunicable Disease Study Group

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.183

Prevalence of diabetes in a predominantly Asian community: preliminary findings of the Coventry diabetes study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.183

Type 2 diabetes prevalence in Asian Americans: results of a national health survey

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.183

Prevalence of diabetes among men and women in China

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.183

Diabetes in sub-Saharan Africa

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.183

Prevalence and time trends in diabetes and physical inactivity among adult West African populations: the epidemic has arrived.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.183

Estimation of diabetes prevalence among immigrants from the Middle East in Sweden by using three different data sources

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.183

High prevalence of diabetes and cardiovascular risk factors associated with urbanization in India

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.183

Risk factors associated with the dramatic increase in the prevalence of diabetes in the adult Chinese population in Qingdao, China

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.183

The global spread of type 2 diabetes mellitus in children and adolescents.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.183

The burden of diabetes mellitus among US youth: prevalence estimates from the SEARCH for Diabetes in Youth Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.183

Increased incidence of non-insulin dependent diabetes mellitus among Japanese schoolchildren correlates with an increased intake of animal protein and fat.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.183

Incidence of diabetes in youth in the United States

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.183

Association testing of TCF7L2 polymorphisms with type 2 diabetes in multi-ethnic youth.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.183

Prevalence of impaired fasting glucose and its relationship with cardiovascular disease risk factors in US adolescents, 1999-2000.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.183

Prevalence of pre-diabetes and its association with clustering of cardiometabolic risk factors and hyperinsulinemia among U.S. adolescents: National Health and Nutrition Examination Survey 2005-2006.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.183

Prevalence of impaired glucose tolerance among children and adolescents with marked obesity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.183

Impaired glucose tolerance and reduced beta-cell function in overweight Latino children with a positive family history for type 2 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.183

The levelling off of the obesity epidemic since the year 1999--a review of evidence and perspectives

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.183

Diabetes trends in the U.S.: 1990-1998.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.183

Diabetes in Hispanic American youth: prevalence, incidence, demographics, and clinical characteristics: the SEARCH for Diabetes in Youth Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.183

Global burden of obesity in 2005 and projections to 2030.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.183

Diet, lifestyle, and the risk of type 2 diabetes mellitus in women

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.183

Effect of BMI on lifetime risk for diabetes in the U.S

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.183

The metabolically obese, normal-weight individual revisited.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.183

Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.183

Impact of BMI and the metabolic syndrome on the risk of diabetes in middle-aged men.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.183

Epidemic obesity and type 2 diabetes in Asia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.183

Ethnic comparisons of the cross-sectional relationships between measures of body size with diabetes and hypertension

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.183

Asians are different from Caucasians and from each other in their body mass index/body fat per cent relationship

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.183

Japanese men have larger areas of visceral adipose tissue than Caucasian men in the same levels of waist circumference in a population-based study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.183

Visceral adipose tissue accumulation differs according to ethnic background: results of the Multicultural Community Health Assessment Trial (M-CHAT)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.183

Point: visceral adiposity is causally related to insulin resistance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.183

Lipids in the wrong place: visceral fat and nonalcoholic steatohepatitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.183

Increased intrahepatic triglyceride is associated with peripheral insulin resistance: in vivo MR imaging and spectroscopy studies.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.183

Alanine aminotransferase, gamma-glutamyltransferase, and incident diabetes: the British Women's Heart and Health Study and meta-analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.183

Pathogenesis of type 2 diabetes: tracing the reverse route from cure to cause

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.183

Perceptions of epigenetics

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.183

Effect of in utero and early-life conditions on adult health and disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.183

Epigenetic mechanisms in the development of type 2 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.183

Birth weight and risk of type 2 diabetes: a systematic review

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.183

The thrifty phenotype hypothesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.183

Glucose tolerance in adults after prenatal exposure to famine

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.183

Exposure to the Chinese famine in early life and the risk of hyperglycemia and type 2 diabetes in adulthood

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.183

Birth weight, type 2 diabetes, and insulin resistance in Pima Indian children and young adults

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.183

Insulin resistance syndrome in 8-year-old Indian children: small at birth, big at 8 years, or both?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.183

Intra-uterine programming of the endocrine pancreas

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.183

Prenatal Growth, BMI, and Risk of Type 2 Diabetes by Early Midlife

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.183

Diabetes and associated disorders in Cambodia: two epidemiological surveys

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.183

Low birth weight and high birth weight infants are both at an increased risk to have type 2 diabetes among schoolchildren in taiwan

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.183

Disorders of glucose regulation in adults and birth weight: results from the Australian Diabetes, Obesity and Lifestyle (AUSDIAB) Study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.183

Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.183

Congenital Susceptibility to NIDDM: Role of Intrauterine Environment

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.183

Intrauterine exposure to diabetes conveys risks for type 2 diabetes and obesity: a study of discordant sibships

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.183

Intrauterine hyperglycemia is associated with an earlier diagnosis of diabetes in HNF-1alpha gene mutation carriers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.183

Effect of a diabetic environment in utero on predisposition to type 2 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.183

Association of exposure to diabetes in utero with adiposity and fat distribution in a multiethnic population of youth: the Exploring Perinatal Outcomes among Children (EPOCH) Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.183

Association between maternal diabetes in utero and age at offspring's diagnosis of type 2 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.183

Gestational glucose tolerance and risk of type 2 diabetes in young Pima Indian offspring.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.183

Trends in the prevalence of preexisting diabetes and gestational diabetes mellitus among a racially/ethnically diverse population of pregnant women, 1999-2005.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.183

Increasing prevalence of gestational diabetes mellitus (GDM) over time and by birth cohort: Kaiser Permanente of Colorado GDM Screening Program

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.183

Gestational diabetes in the United States: temporal trends 1989 through 2004.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.183

TCF7L2 is reproducibly associated with type 2 diabetes in various ethnic groups: a global meta-analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.183

Genomics, type 2 diabetes, and obesity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.183

Predicting diabetes: clinical, biological, and genetic approaches: data from the Epidemiological Study on the Insulin Resistance Syndrome (DESIR).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.183

Use of multiple metabolic and genetic markers to improve the prediction of type 2 diabetes: the EPIC-Potsdam Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.183

Assessing the combined impact of 18 common genetic variants of modest effect sizes on type 2 diabetes risk

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.183

Clinical risk factors, DNA variants, and the development of type 2 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.183

Genotype score in addition to common risk factors for prediction of type 2 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.183

Predicting type 2 diabetes based on polymorphisms from genome-wide association studies: a population-based study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.183

Utility of genetic and non-genetic risk factors in prediction of type 2 diabetes: Whitehall II prospective cohort study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.183

Genetic risk reclassification for type 2 diabetes by age below or above 50 years using 40 type 2 diabetes risk single nucleotide polymorphisms.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.183

Genetic predisposition, Western dietary pattern, and the risk of type 2 diabetes in men.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.183

Physical Activity, Diet, and Incident Diabetes in Relation to an ADRA2B Polymorphism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.183

TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.183

Variants of transcription factor 7-like 2 (TCF7L2) gene predict conversion to type 2 diabetes in the Finnish Diabetes Prevention Study and are associated with impaired glucose regulation and impaired insulin secretion

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.183

The clinical application of genetic testing in type 2 diabetes: a patient and physician survey

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.183

Perceived impact of diabetes genetic risk testing among patients at high phenotypic risk for type 2 diabetes.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.183

Sleep-disordered breathing and type 2 diabetes: a report from the International Diabetes Federation Taskforce on Epidemiology and Prevention

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.183

Depression and type 2 diabetes over the lifespan: a meta-analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.183

Antidepressant medication use, weight gain, and risk of type 2 diabetes: a population-based study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.183

Endocrine disruptors in the etiology of type 2 diabetes mellitus.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.183

Particulate matter air pollution and cardiovascular disease: An update to the scientific statement from the American Heart Association

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.183

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.183

Relationship between glycated haemoglobin levels and mean glucose levels over time

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.183

Standards of medical care in diabetes--2010.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.183

A1C level and future risk of diabetes: a systematic review

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.183

Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.183

Haemoglobin A1c levels and subsequent cardiovascular disease in persons without diabetes: a meta-analysis of prospective cohorts

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.183

International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.183

Glycemic thresholds for diabetes-specific retinopathy: implications for diagnostic criteria for diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.183

Performance of an A1C and fasting capillary blood glucose test for screening newly diagnosed diabetes and pre-diabetes defined by an oral glucose tolerance test in Qingdao, China

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.183

Moving to an A1C-based diagnosis of diabetes has a different impact on prevalence in different ethnic groups

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.183

Prevalence of diabetes and high risk for diabetes using A1C criteria in the U.S. population in 1988-2006

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.183

Relationship between A1C and glucose levels in the general Dutch population: the new Hoorn study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.183

A1C and diabetes diagnosis among Filipino Americans, Japanese Americans, and Native Hawaiians

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.183

Screening for diabetes and pre-diabetes with proposed A1C-based diagnostic criteria

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.183

Differences in cardiovascular risk profile of diabetic subjects discordantly classified by diagnostic criteria based on glycated hemoglobin and oral glucose tolerance test

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.183

The potential impact of using glycated haemoglobin as the preferred diagnostic tool for detecting Type 2 diabetes mellitus.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.183

Glycated haemoglobin A1c for diagnosing diabetes in Chinese population: cross sectional epidemiological survey

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.183

Elevated A1C in adults without a history of diabetes in the U.S.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.183

A1C cut points to define various glucose intolerance groups in Asian Indians

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.183

HbA(1c) as a screening tool for detection of Type 2 diabetes: a systematic review

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.183

HbA1c and cardiovascular risk score identify people who may benefit from preventive interventions: a 7 year follow-up of a high-risk screening programme for diabetes in primary care (ADDITION), Denmark.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.183

Impact of A1C screening criterion on the diagnosis of pre-diabetes among U.S. adults.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.183

Annual incidence and relative risk of diabetes in people with various categories of dysglycemia: a systematic overview and meta-analysis of prospective studies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.183

Lifestyle risk factors and new-onset diabetes mellitus in older adults: the cardiovascular health study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.183

Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta-analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.183

Determinants for the effectiveness of lifestyle intervention in the Finnish Diabetes Prevention Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.183

Risk assessment tools for identifying individuals at risk of developing type 2 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.183

Maximizing efficiency and cost-effectiveness of Type 2 diabetes screening: the AusDiab study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.183

Lifestyle intervention for prevention of type 2 diabetes in primary health care: one-year follow-up of the Finnish National Diabetes Prevention Program (FIN-D2D).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.183

Implementation and effectiveness of the first community lifestyle intervention programme to prevent Type 2 diabetes in Greece. The DE-PLAN study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.183

Sick individuals and sick populations

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.183

Body mass index history and risk of type 2 diabetes: results from the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study

31 March 2020

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22064493

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Type 2 diabetes in Indigenous and non-Indigenous children and adolescents in New South Wales.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22064493

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/NRENDO.2011.183

1 reference

PubMed ID

22064493

Dimensions Publication ID

25 August 2017

0 references

1 reference

PubMed ID

22064493